The activity of tPA is regulated at multiple levels, including gene expression, post-translational modifications, and interactions with inhibitors. The balance between tPA and its inhibitors, such as PAI-1, is critical for maintaining hemostasis. Dysregulation of this balance can lead to pathological conditions, including bleeding disorders and thrombosis.